Tm. Joneswilson et al., NEW HYDROXYBENZYL AND HYDROXYPYRIDYLMETHYL SUBSTITUTED TRIAZACYCLONONANE LIGANDS FOR USE WITH GALLIUM(III) AND INDIUM(III), Nuclear medicine and biology, 22(7), 1995, pp. 859-868
The Ga-67(III) and/or In-111(III) complexes of four new hexadentate li
gands have been prepared and evaluated in vitro and in vivo. These sub
stituted triazacyclononane ligands bind the metal ion through three te
rtiary ring nitrogens and three oxygens from pendant phenolic or hydro
xypyridyl arms. The hydroxypyridyl moieties increase the aqueous solub
ility of the metal complexes while retaining a lipophilic character. A
s indicated by their large positive partition coefficients, the phenol
ic ligands proved to be significantly more lipophilic than the hydroxy
pyridyl ligands. Biodistribution in Sprague-Dawley rats indicated that
the more lipophilic phenolic complexes cleared the body primarily thr
ough the liver, while the less lipophilic hydroxypyridyl complexes cle
ared rapidly, primarily through the kidney. To differentiate the clear
ance characteristics of these radiolabeled compounds, radiochemical pu
rity of selected complexes in vivo was measured. The complexes were ev
aluated for overall charge in vitro and in vivo, in plasma samples. In
addition, plasma and urine were analyzed for possible metabolites. Wi
th one exception, each complex was unmetabolized in vivo. All complexe
s and metabolites formed were neutral in vitro and in vivo. Extended s
tability in serum of selected radiometal complexes has been measured.
Each complex measured was stable to exchange with transferrin, up to 7
2 h, as expected from the large stability constants of the complexes.
The clearance characteristics of the hydroxypyridyl and phenolic ligan
ds, however, were markedly different. The rapid hepatic clearance of t
he phenolic ligands indicates potential as bifunctional chelates for G
a(III) or In(III).